MARKET WIRE NEWS
  1. Home
  2. Stock
  3. ALVO
  4. News
ALVO
Quote
Short
News
Articles
Message Board

Alvotech (NASDAQ : ALVO ) News

Alvotech (NASDAQ: ALVO) News Releases

ALVO News Releases
ALVO : NASDAQ
SeekingAlpha
Alvotech (ALVO) Discusses Launch of $125 Million Commercial Bond Offering and Business Update Transcript
ALVO : NASDAQ
SeekingAlpha
Regeneron Pharmaceuticals: Is Wall Street Finally Paying Attention?
ALVO : NASDAQ
SeekingAlpha
Alvotech's AVT03 approved by European Commission as biosimilar to Prolia and Xgeva
ALVO : NASDAQ
GlobeNewswire
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area
ALVO : NASDAQ
SeekingAlpha
Alvotech, Advanz Pharma secure European approval for Gobivaz, Simponi biosimilar
ALVO : NASDAQ
GlobeNewswire
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)
ALVO : NASDAQ
Business Wire
ALVO Investigation: Investors Encouraged to Contact Kirby McInerney LLP
ALVO : NASDAQ
SeekingAlpha
Generics Stalwart Teva Has Turned A Corner In Its Specialty Medicines Business
ALVO : NASDAQ
SeekingAlpha
Alvotech (ALVO) Q3 2025 Earnings Call Transcript
ALVO : NASDAQ
SeekingAlpha
Alvotech GAAP EPS of $0.47 beats by $0.49
Back to Start

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.